Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by AVITA Medical

< Previous 1 2 Next >
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Updates Full Year 2023 Guidance
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Announce Third Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Present at the Cantor Global Healthcare Conference
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Participate in Upcoming Investor Conferences
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Reports Second Quarter Financial Results
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Announce Second Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Submits FDA PMA Supplement for RECELL GO
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Rejoins the Russell 3000 Index
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Announce First Quarter 2023 Financial Results
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces Update to Automation Device
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Financial Guidance
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
From AVITA Medical
Via GlobeNewswire
Tickers ASX:AVH RCEL
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.